COMPARISON OF SWITCHING TO REDUCED DOSE VS CONTINUATION OF STANDARD DOSE ETANERCEPT FOR RHEUMATOID ARTHRITIS PATIENTS IN THE CORRONA REGISTRY

被引：2
|
作者：
Greenberg, J. D. [1 ,2 ]
Shan, Y. [2 ]
Reed, G. W. [2 ,3 ]
Bitman, B. [4 ]
Collier, D. [5 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] CORRONA Inc, Southborough, MA USA
[3] Univ Massachusetts, Sch Med, Worcestesr, MA USA
[4] Amgen Inc, San Francisco, CA USA
[5] Amgen Inc, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1836
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0174
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [41] Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
    Dimitrios A. Pappas
    Joel M. Kremer
    Jenny Griffith
    George Reed
    Bob Salim
    Chitra Karki
    Vishvas Garg
    Rheumatology and Therapy, 2017, 4 : 375 - 389
  • [42] Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience
    Oscar Epis
    Cinzia Casu
    Laura Belloli
    Emanuela Schito
    Davide Filippini
    Marina Muscarà
    Eleonora Bruschi
    Rheumatology International, 2015, 35 : 1569 - 1570
  • [43] Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience
    Epis, Oscar
    Casu, Cinzia
    Belloli, Laura
    Schito, Emanuela
    Filippini, Davide
    Muscara, Marina
    Bruschi, Eleonora
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (09) : 1569 - 1570
  • [44] Efficacy of High-Dose Versus Standard-Dose Influenza Vaccine in Seropositive Rheumatoid Arthritis Patients
    Colmegna, Ines
    Useche, Mariana
    Rodriguez, Katherine
    Hudson, Marie
    Bernatsky, Sasha
    Nedjar, Hacene
    Rahme, Elham
    Ward, Brian
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [45] Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis
    Karin Laas
    Ritva Peltomaa
    Hannu Kautiainen
    Marjatta Leirisalo-Repo
    Clinical Rheumatology, 2008, 27 : 927 - 932
  • [46] Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis
    Laas, Karin
    Peltomaa, Ritva
    Kautiainen, Hannu
    Leirisalo-Repo, Marjatta
    CLINICAL RHEUMATOLOGY, 2008, 27 (07) : 927 - 932
  • [47] The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.
    Hansen, KE
    Cush, JJ
    Patel, S
    Genovese, MC
    Schiff, M
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S538 - S538
  • [48] Comparison of Low-Dose Interleukin 2 Therapy in Conjunction With Standard Therapy in Patients With Systemic Lupus Erythematosus vs Rheumatoid Arthritis: A Systematic Review
    Riaz, Muhammad Faisal
    Garg, Gourav
    Umeano, Lotanna
    Iftikhar, Sadaf
    Alhaddad, Sarah F.
    Paulsingh, Christian N.
    Hamid, Pousette
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [49] Adopting Low-Dose Etanercept Strategy in the Long-Term Management of Rheumatoid Arthritis Patients
    Raffeiner, Bernd
    Botsios, Costantino
    Todesco, Silvano
    Bernardi, Livio
    Ometto, Francesca
    Vezzari, Cristiana
    Sfriso, Paolo
    Punzi, Leonardo
    CLINICAL DRUG INVESTIGATION, 2013, 33 : S128 - S130
  • [50] Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
    Chen, Hsin-Hua
    Chen, Der-Yuan
    Chen, Yi-Ming
    Tang, Chao-Hsiun
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 123 - 134
12345